ArticleCancer chemotherapy and pharmacology2008

Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors.

Wells A Messersmith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.